Heterogeneity-mediated cellular adaptation and its trade-off: searching for the general principles of diseases

Journal of Evaluation in Clinical Practice

Volumn 23, Issue 1, 2017, Pages 233-237

  Heng, Henry H ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive system; cellular evolution; common mechanism of diseases; fuzzy inheritance; genetic coding; genome theory; heterogeneity; stress response; system inheritance

Indexed keywords

ADAPTATION; ARTICLE; CELLULAR ADAPTATION; CELLULAR EVOLUTION; CHROMOSOME ABERRATION; DISEASES; EVOLUTION; GENE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENOME; HETEROGENEITY MEDIATED CELLULAR ADAPTIVE MODEL; HUMAN; INHERITANCE; MOLECULAR MODEL; PARTS INHERITANCE; STRESS; SYSTEM INHERITANCE; BIOLOGY; GENETICS; GENOMICS; MENTAL STRESS; MUTATION; ORGANIZATION AND MANAGEMENT; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; PROCEDURES;

ADAPTATION, PHYSIOLOGICAL; BIOLOGICAL EVOLUTION; COMPUTATIONAL BIOLOGY; GENOMICS; HUMANS; MUTATION; PRECISION MEDICINE; STRESS, PSYCHOLOGICAL;

EID: 84992110979     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/jep.12598     Document Type: Article

References (47)

1. Heng, H. H. (2016a) Debating Cancer: The Paradox in Cancer Research. Singapore: World Scientific, World Scientific Publishing.
2. Sturmberg, J. P. & Martin, C. P. (2013) Complexity in Health: An Introduction. In Handbook on Systems and Complexity in Health (eds J. P. Sturmberg & C. M. Martin), pp. 1–17. New York: Springer.
3. Sturmberg, J. P. (2016) “Returning to Holism”: An Imperative for the Twenty-First Century. In The Value of Systems and Complexity Sciences for Healthcare (ed. J. P. Sturmberg), pp. 3–19. Switzerland: Springer.
4. Nesse, R. M., Ganten, D., Gregory, T. R. & Omenn, G. S. (2012) Evolutionary molecular medicine. J Mol Med (Berl), 90 (5), 509–22.
5. Ball, P. (2013) DNA: Celebrate the unknowns. Nature, 496, 419–420.
6. Interlandi, J. (2016) The paradox of precision medicine. Scientific American, 314 (4), 24, B24.
7. Heng, H. H. (2008) The conflict between complex systems and reductionism. JAMA, 300 (13), 1580–1581.
8. Heng, H. H. (2016b) Genomic landscape of cancer. In Ecology and Evolution in Cancer (eds B. Ujvari, B. Roche & F. Thomas) (in press). San Diego: Elsevier.
9. Horne, S. D., Ye, C. J., Abdallah, B. Y., Liu, G. & Heng, H. H. (2015a) Cancer genome evolution. Transl Cancer Res, 4 (3), 303–313.
10. Heng, H. H. (2007) Cancer genome sequencing: the challenges ahead. Bioessays, 29, 783–794.
11. Heng, H. H., Horne, S. D., Stevens, J. B., Abdallah, B. Y., Liu, G., Chowdhury, S. K., Bremer, S. W., Zhang, K. & Ye, C. J. (2016a) Heterogeneity mediated system complexity: The ultimate challenge for studying common and complex diseases. In (eds The Value of Systems and Complexity Sciences for Healthcare & J. P. Sturmberg), pp. 107–120. Switzerland: Springer.
12. Heng, H. H., Regan, S. & Ye, C. J. (2016b) Genotype, environment, and evolutionary mechanism of diseases. Environ Dis, 1, 14–23.
13. Horne, S. D., Chowdhury, S. K. & Heng, H. H. (2014) Stress, genomic adaptation, and the evolutionary trade-off. Frontiers in Genetics, 5 (92), 1–6.
14. Heng, H. H. (2010) Missing heritability and stochastic genome alterations. Nature Reviews Genetics, 11, 813.
15. Heng, H. H. (2009) The genome-centric concept: resynthesis of evolutionary theory. Bioessays, 31, 512–525.
16. Heng, H. H., Liu, G., Stevens, J. B., Bremer, S. W., Ye, K. J., Abdallah, B. Y., Horne, S. D. & Ye, C. J. (2011a) Decoding the genome beyond sequencing: the new phase of genomic research. Genomics, 98, 242–252.
17. Heng, H. H., Bremer, S. W., Stevens, J. B., Ye, K. J., Liu, G. & Ye, C. J. (2009) Genetic and epigenetic heterogeneity in cancer: a genome-centric perspective. Journal of Cellular Physiology, 220 (3), 538–47.
18. Horne, S. D., Ye, C. J. & Heng, H. H. (2015b) Chromosomal instability (CIN) in cancer. eLS, 1–9.
19. Horne, S. D., Pollick, S. A. & Heng, H. H. (2015c) Evolutionary mechanism unifies the hallmarks of cancer. International Journal of Cancer, 136, 2012–2021.
20. Heng, H. H., Bremer, S. W., Stevens, J. B., Horne, S. D., Liu, G., Abdallah, B. Y., Ye, K. J. & Ye, C. J. (2013a) Chromosomal instability (CIN): what it is and why it is crucial to cancer evolution. Cancer and Metastasis Reviews, 32, 325–340.
21. Heng, H. H., Liu, G., Stevens, J. B., Abdallah, B. Y., Horne, S. D., Ye, K. J., Bremer, S. W., Chowdhury, S. K. & Ye, C. J. (2013b) Karyotype heterogeneity and unclassified chromosomal abnormalities. Cytogenetic and Genome Research, 139, 144–157.
22. Huang, S. (2013) Genetic and non-genetic instability in tumor progression: link between the fitness landscape and the epigenetic landscape of cancer cells. Cancer and Metastasis Reviews, 32, 423–448.
23. Rancati, G., Pavelka, N., Fleharty, B., Noll, A., Trimble, R., Walton, K., Perera, A., Staehling-Hampton, K., Seidel, C. W. & Li, R. (2008) Aneuploidy underlies rapid adaptive evolution of yeast cells deprived of a conserved cytokinesis motor. Cell, 135 (5), 879–893.
24. Zhang, K., Wong, H. N., Song, B., Miller, C. N., Scheuner, D. & Kaufman, R. J. (2005) The unfolded protein response sensor IRE1 alpha is require dat2 distinct steps in B cell lymphopoiesis. Journal of Clinical Investigation, 115, 268–281.
25. Abdallah, B. Y., Horne, S. D., Steven, J. B., Liu, G., Ying, A. Y., Vanderhyden, B., Krawetz, S. A., Gorelick, R. & Heng, H. H. (2013) Single cell heterogeneity: why unstable genomes are incompatible with average profiles. Cell Cycle, 12 (23), 3640–3649.
26. Stevens, J. B., Abdallah, B. Y., Liu, G., et al. (2011) Diverse system stresses: common mechanisms of chromosome fragmentation. Cell Death & Disease, 2, e178.
27. Heng, H. H., Stevens, J. B., Bremer, S. W., Liu, G., Abdallah, B. Y. & Ye, C. J. (2011b) Evolutionary mechanisms and diversity in cancer. Advances in Cancer Research, 112, 217–253.
28. Liu, G., Stevens, J. B., Horne, S. D., Abdallah, B. Y., Ye, K. J., Bremer, S. W., Ye, C. J., Chen, D. J. & Heng, H. H. (2014) Genome chaos: survival strategy during crisis. Cell Cycle, 13, 528–537.
29. Heng, H. H., Stevens, J. B., Liu, G., Bremer, S. W., Ye, K. J., Reddy, P. V., Wu, G. S., Wang, Y. A., Tainsky, M. A. & Ye, C. J. (2006) Stochastic cancer progression driven by non-clonal chromosome aberrations. Journal of Cellular Physiology, 208, 461–472.
30. Baca, S. C., Prandi, D., Lawrence, M. S., et al. (2013) Punctuated evolution of prostate cancer genomes. Cell, 153, 666–677.
31. Ling, S., Hu, Z., Yang, Z., et al. (2015) Extremely high genetic diversity in a single tumor points to prevalence of non-Darwinian cell evolution. Proceedings of the National Academy of Sciences of the United States of America, 112, E6496–6505.
32. Navin, N., Kendall, J., Troge, J., et al. (2011) Tumour evolution inferred by single-cell sequencing. Nature, 472, 90–94.
33. Stephens, P. J., Greenman, C. D., Fu, B., et al. (2011) Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell, 144, 27–40.
34. Sottoriva, A., Kang, H., Ma, Z., et al. (2015) A Big Bang model of human colorectal tumor growth. Nature Genetics, 47, 209–16.
35. Stevens, J. B., Horne, S. D., Abdallah, B. Y., Ye, C. J. & Heng, H. H. (2013) Chromosomal instability and transcriptome dynamics in cancer. Cancer and Metastasis Reviews, 32, 391–402.
36. Stevens, J. B., Liu, G., Abdallah, B. Y., Horne, S. D., Ye, K. J., Bremer, S. W., Ye, C. Y., Krawetz, S. K. & Heng, H. H. (2014) Unstable genome elevate transcriptome dynamics. International Journal of Cancer, 134, 2074–2087.
37. Heng, H. H. (2013) Bio-complexity: challenging reductionism. In Handbook on Systems and Complexity in Health (eds J. P. Sturmberg & C. M. Martin), pp. 193–208. New York: Springer.
38. Sturmberg, J. P., Bennett, J. M., Martin, C. M. & Picard, M. (2017) “Multimorbidity” as the manifestation of network disturbances. Journal of Evaluation in Clinical Practice, 23 (1), 199–208.
39. Goh, K. I., Cusick, M. E., Valle, D., Childs, B., Vidal, M. & Barabási, A. L. (2007) The human disease network. Proceedings of the National Academy of Sciences of the United States of America, 104 (21), 8685–8690.
40. Duesberg, P. & McCormack, A. (2013) Immortality of cancers: a consequence of inherent karyotypicvariations and selections for autonomy. Cell Cycle, 12 (5), 783–802.
41. Hultén, M. A., Jonasson, J., Iwarsson, E., Uppal, P., Vorsanova, S. G., Yurov, Y. B. & Iourov, I. Y. (2013) Trisomy 21 mosaicism: we may all have a touch of Down syndrome. Cytogenetic and Genome Research, 139 (3), 189–192.
42. Iourov, I. Y., Vorsanova, S. G. & Yurov, Y. B. (2008) Chromsomal mosaicism goes global. Molecular Cytogenetics, 1, 26.
43. Podlaha, O., Riester, M., De, S. & Michor, F. (2012) Evolution of the cancer genome. Trends in Genetics, 28, 155–163.
44. Yurov, Y. B., Vorsanova, S. G., Liehr, T., Kolotii, A. D. & Iourov, I. Y. (2014) X chromosome aneuploidy in the Alzheimer's disease brain. Molecular Cytogenetics, 7 (1), 20.
45. Biesterfeld, S., Gerres, K., Fischer-Wein, G. & Böcking, A. (1994) Polyploidy in non-neoplastic tissues. Journal of Clinical Pathology, 47 (1), 38–42.
46. Duncan, A. W., Taylor, M. H., Hickey, R. D., Hanlon Newell, A. E., Lenzi, M. L., Olson, S. B., Finegold, M. J. & Grompe, M. (2010) The ploidy conveyor of mature hepatocytes as a source of genetic variation. Nature, 467, 707–710.
47. Martincorena, I., Roshan, A., Gerstung, M., et al. (2015) Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin. Science, 348, 880–886.